Insulet Corporation (PODD)

Insulet Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	2,708	2,072	1,697	1,305	1,099
Revenue Growth (YoY)	30.73%	22.07%	30.02%	18.79%	21.50%
Cost of Revenue	768.2	625.9	537.2	499.7	346.7
Gross Profit	1,940	1,446	1,160	805.6	752.1
Selling, General & Admin	1,165	917.2	734.8	587.8	466
Research & Development	301.1	219.6	205	180.2	160.1
Total Operating Expenses	1,466	1,137	939.8	768	626.1
Operating Income	473.8	308.9	220.1	37.6	126
Interest Income	34.7	39.5	28.6	9.3	0.5
Interest Expense	-59.4	-42.7	-36.2	-36	-61.7
Other Non-Operating Income (Expense)	-109.6	-5.5	2.2	-1.1	-44.3
Total Non-Operating Income (Expense)	-134.3	-8.7	-5.4	-27.8	-105.5
Pretax Income	339.5	300.2	214.7	9.8	20.5
Provision for Income Taxes	-92.4	118.1	-8.3	-5.2	-3.7
Net Income	247.1	418.3	206.3	4.6	16.8
Net Income to Common	247.1	418.3	206.3	4.6	16.8
Net Income Growth	-40.93%	102.76%	4384.78%	-72.62%	147.06%
Shares Outstanding (Basic)	70	70	70	69	68
Shares Outstanding (Diluted)	72	74	74	70	69
Shares Change (YoY)	-2.71%	0.35%	5.33%	1.94%	3.99%
EPS (Basic)	3.51	5.97	2.96	0.07	0.25
EPS (Diluted)	3.48	5.78	2.94	0.07	0.24
EPS Growth	-39.79%	96.60%	4100.00%	-70.83%	140.00%
Free Cash Flow	377.7	305.3	70.1	-3.9	-180
Free Cash Flow Growth	23.71%	335.52%	-	-	-
Free Cash Flow Per Share	5.25	4.13	0.95	-0.06	-2.62
Gross Margin	71.63%	69.79%	68.35%	61.72%	68.45%
Operating Margin	17.50%	14.91%	12.97%	2.88%	11.47%
Profit Margin	9.12%	20.19%	12.16%	0.35%	1.53%
FCF Margin	13.95%	14.74%	4.13%	-0.30%	-16.38%
EBITDA	564.2	389.7	292.9	100.8	183.4
EBITDA Margin	20.83%	18.81%	17.26%	7.72%	16.69%
EBIT	473.8	308.9	220.1	37.6	126
EBIT Margin	17.50%	14.91%	12.97%	2.88%	11.47%
Effective Tax Rate	-27.22%	39.34%	-3.87%	-53.06%	-18.05%

Updated Feb 18, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q